Durability of immune responses to SARS-CoV-2 infection and vaccination

Seminars in Immunology · Published 2024-05-01 · DOI 10.1016/j.smim.2024.101884

Authors being retrieved — see the publisher record. https://doi.org/10.1016/j.smim.2024.101884

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2024

Related articles

• Vaccines for the Prevention of COVID-19 in Older Adults · Clinics in Geriatric Medicine · 2026 · Cites or is cited by this article
• Oncolytic virus-mediated immunomodulation in glioblastoma: Insights from clinical trials and challenges · Seminars in Immunology · 2025 · Same journal
• From immunobiology to intervention: Pathophysiology of autoimmune encephalitis · Seminars in Immunology · 2025 · Same journal
• Global aspects of celiac disease and food allergy · Seminars in Immunology · 2025 · Same journal
• Antiviral humoral immunity: Enemy or ally of viral immunotherapy? · Seminars in Immunology · 2025 · Same journal
• Three’s company: The cooperative signals behind the differentiation of Th9 cells · Seminars in Immunology · 2025 · Same journal
• Autoimmune diabetes and targets for immunomodulation · Seminars in Immunology · 2025 · Same journal
• The multifaceted role of B lymphocytes in type 1 diabetes · Seminars in Immunology · 2026 · Same journal
• Reovirus oncolysis and the next frontiers for this unique oncoviral immunotherapy · Seminars in Immunology · 2025 · Same journal
• Emerging roles of IL-9 and Th9 cells in respiratory viral illnesses · Seminars in Immunology · 2026 · Same journal